Apontis Pharma AG (XTER:APPH) Short-Term Capital Lease Obligation : €0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Apontis Pharma AG Short-Term Capital Lease Obligation?

Apontis Pharma AG's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was €0.00 Mil.

Apontis Pharma AG Short-Term Capital Lease Obligation Historical Data

The historical data trend for Apontis Pharma AG's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apontis Pharma AG Short-Term Capital Lease Obligation Chart

Apontis Pharma AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

Apontis Pharma AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial							-	-	-	-	-

Apontis Pharma AG Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Apontis Pharma AG Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Apontis Pharma AG's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Apontis Pharma AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rolf-Schwarz-Schutte-Platz 1, Monheim, BY, DEU, 40789

Website

https://www.apontis-pharma.de

Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.

Executives

Bruno Wohlschlegel	Board of Directors
Thomas Milz	Board of Directors
Thomas Zimmermann	Chief Financial Officer
Karlheinz Gast	Board of Directors

Apontis Pharma AG Headlines

No Headlines